Lichtheimia corymbifera
Lichtheimia corymbifera is a species of fungus that belongs to the family Lichtheimiaceae. It is a thermophilic fungus, meaning it thrives in high-temperature environments. L. corymbifera is one of the most common causes of mucormycosis, a serious and often deadly fungal infection.
Taxonomy[edit]
Lichtheimia corymbifera was first described in 1896 by German mycologist Karl Lichtheim. The genus name Lichtheimia is derived from his surname, while the species name corymbifera refers to the corymb-like structure of its sporangia.
Description[edit]
L. corymbifera is a saprophytic fungus, meaning it feeds on dead or decaying organic matter. It produces large, round sporangia that are filled with numerous spores. These spores are released into the environment and can cause infection if inhaled or ingested by a susceptible host.
Pathogenicity[edit]
L. corymbifera is a pathogenic fungus that can cause mucormycosis, a serious fungal infection that primarily affects individuals with weakened immune systems. The infection can manifest in various forms, including rhinocerebral, pulmonary, cutaneous, gastrointestinal, and disseminated mucormycosis. Treatment typically involves antifungal medications and surgical debridement of infected tissues.
Epidemiology[edit]
L. corymbifera is found worldwide, but it is most common in tropical and subtropical regions. It is often found in soil, decaying vegetation, and compost piles. Infections are relatively rare but can be severe or fatal, particularly in individuals with weakened immune systems.
Research[edit]
Research on L. corymbifera has focused on understanding its pathogenicity and developing effective treatments for mucormycosis. Recent studies have also explored its potential for biotechnological applications, such as the production of biofuels and enzymes.
Lichtheimia corymbifera[edit]
-
Absidia corymbifera
-
Absidia corymbifera apophysis
-
Absidia corymbifera sporangium
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian

